BrainsWay Reveals Promising 12-Month Results for Accelerated Deep TMS Treatment
BrainsWay Presents First SWIFTTM Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting
Image: Benzinga
BrainsWay Ltd. presented new 12-month data on its SWIFTTM accelerated Deep TMS treatment for Major Depressive Disorder, showing over 80% remission rates and significant functional improvements among patients. The findings were shared at the Clinical TMS Society Annual Meeting in June 2026.
- 01Over 80% of patients treated with the SWIFTTM protocol remained in remission after 12 months.
- 02The percentage of patients with severe functional impairment dropped from 85% to 0% over the same period.
- 03Less than 25% of patients required medication changes or additional TMS treatments within the year.
- 04The study is the first to evaluate one-year durability of both accelerated and conventional Deep TMS protocols.
- 05The SWIFTTM protocol significantly reduces clinic visits by 70% compared to traditional methods.
Advertisement
In-Article Ad
BrainsWay Ltd., a leader in noninvasive neurostimulation for mental health, presented compelling 12-month durability data for its SWIFTTM accelerated Deep Transcranial Magnetic Stimulation (Deep TMS) treatment for Major Depressive Disorder (MDD) at the Clinical TMS Society Annual Meeting held from June 4-6, 2026. The study, led by Dr. Colleen Hanlon, showed that over 80% of patients maintained remission after one year, with a remarkable decrease in severe functional impairment from 85% to 0%. Additionally, fewer than 25% of patients needed changes in medication or further TMS treatments during this period, indicating the long-term effectiveness of the SWIFTTM protocol. This protocol, which allows for a 70% reduction in clinic visits compared to traditional methods, represents a significant advancement in treatment accessibility and effectiveness. The findings underscore the importance of sustained symptom relief, as highlighted by BrainsWay's CEO Hadar Levy, who noted that these results pave the way for improved mental health care options.
Advertisement
In-Article Ad
The findings suggest a significant improvement in the quality of life for patients suffering from Major Depressive Disorder, potentially reducing the burden on healthcare systems.
Advertisement
In-Article Ad
Reader Poll
What do you think about the effectiveness of accelerated Deep TMS treatments?
Connecting to poll...
Read the original article
Visit the source for the complete story.